SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
141.60    -24.20 (-14.60%)
Bid:
140.20
Ask:
144.80
Spread: 4.60 (3.281%)
Market Cap: £241.94m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Pre-close Trading Statement

24 Jun 2010 07:00

RNS Number : 1459O
McBride PLC
24 June 2010
 



24th June 2010

 

McBride PLC

 

Pre-close Trading Statement

 

McBride PLC, Europe's leading provider of private label household and personal care products, today provides an update on trading for the year ended 30 June 2010 prior to entering its closed period.

 

The Board expects to report operating profits for the year in line with its expectations.

 

The Group anticipates reporting full-year revenue growth, on a constant currency basis, to be flat following a fourth quarter that is expected to be 3% lower than prior year. This reflects ongoing branded promotional activity in UK combined with weak retail sales across Europe.

 

The Group is seeing prices for key raw materials increasing by 4% by the end of June compared with December 2009. We believe our markets will remain volatile and there remains a significant risk that our material costs will rise by a further 4-6% during the next financial year. Our business model is designed to manage raw material increases effectively, although inevitably there will be a delay before recovery from customers.

 

Year-end net debt is expected to be in line with expectations reflecting continued strong cash flows. In addition, McBride is pleased to announce that a new five-year €175m revolving credit facility agreement has been concluded with our banks on attractive terms.

 

As part of the Group's continuing focus on driving operational efficiencies, a further re-structuring project has been initiated in UK and is expected to deliver annualised cost savings of £4m with cash expenditure of £4m. The cost of this initiative will be treated as an exceptional item, resulting in a total exceptional charge for 2009/10 in the region of £14m.

 

The group intends to announce its preliminary results for the year ended 30 June 2010 on 2 September 2010.

 

 

For further information please contact:

 

McBride PLC

Chris Bull, Chief Executive

020 7539 7852

Richard Armitage, Group Finance Director

020 7539 7851

Financial Dynamics

Ben Foster

020 7269 7247

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUCAQUPUGAW
Date   Source Headline
12th Jun 20267:00 amRNSTrading and Acquisition Update
11th Jun 20261:44 pmRNSDirector/PDMR Shareholding
2nd Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSSecond tranche of share buyback programme
1st May 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSProposed Acquisition & Trading Conditions Update
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSDirector Appointment
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20266:28 pmRNSDirectorate change
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:05 amRNSInterim results for 6M ended 31 December 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.